| Martínez-Revelles S, Avendaño MS, Garcia-Redondo AB, Alvarez Y, Aguado A, Pérez-Girón JV, García-Redondo L, Esteban V, Redondo JM, Alonso MJ, Briones AM, Salaices M. Reciprocal relationship between reactive oxygen species and cyclooxygenase-2 and vascular dysfunction in hypertension. Antioxid Redox Sign (2013) 18:51-65 |
| Salvado MD, Alfranca A, Haeggström JZ, Redondo JM. Prostanoids in tumor angiogenesis: therapeutic intervention beyond COX-2. Trends Mol Med (2012) 18:233-43 |
| Alcolea S, Anton R, Camacho M, Soler M, Alfranca A, Aviles-Jurado FX, Redondo JM, Quer M, Leon X, Vila L. Interaction between head and neck squamous cell carcinoma (HNSCC) cells and fibroblasts in the biosynthesis of PGE2. J Lipid Res (2012) 53:630-42 |
| Rodríguez P, Higueras MA, González-Rajal A, Alfranca A, Fierro-Fernández M, García-Fernández RA, Ruiz-Hidalgo MJ, Monsalve M, Rodríguez-Pascual F, Redondo JM, de la Pompa JL, Laborda J, Lamas S. The non-canonical NOTCH ligand DLK1 exhibits a novel vascular role as a strong inhibitor of angiogenesis. Cardiovasc Res (2012) 93:232-41 |
| Esteban V, Mendez-Barbero N, Jimenez-Borreguero JL, Roque M, Novensa L, Garcia-Redondo AB, Salaices M, Vila L, Albonés ML, Campanero MR and Redondo JM. Regulator of calcineurin 1 mediates pathological vascular wall remodeling. J Exp Med (2011) 208:2125-39 |
| Urso K, Alfranca A, Martinez-Martinez S, Escolano A, Ortega I, Rodriguez A, Redondo JM. NFATc3 regulates the transcription of genes involved in T cell activation and angiogenesis. Blood (2011) 118:795-803 |
| Bonzon-Kulichenko E, Perez-Hernandez D, Nunez E, Martinez-Acedo P, Navarro P, Trevisan-Herraz M, Ramos MD, Sierra S, Martinez-Martinez S, Ruiz-Meana M, Miro-Casas E, Garcia-Dorado D, Redondo JM, Burgos JS, Vazquez J. A robust method for quantitative high-throughputanalysis of proteomes by 18O labeling. Mol Cell Proteomics (2011) 10:M110.003335 |
| Gómez-Del Arco P, Kashiwagi M, Jackson AF, Naito T, Zhang J, Liu F, Kee B, Vooijs M, Radtke F, Redondo JM, Georgopoulos K. Alternative promoter usage at the notch1 locus supports ligand-independent signaling in T cell development and leukemogenesis. Immunity (2010) 33:685-98 |
| Cubelos B, Sebastián-Serrano A, Beccari L, Calcagnotto ME, Cisneros E, Kim S, Dopazo A, Alvarez-Dolado M, Redondo JM, Bovolenta P, Walsh CA, Nieto M. Cux1 and Cux2 regulate dendritic branching, spine morphology, and synapses of the upper layer neurons of the cortex. Neuron (2010) 66:523-35 |
| Salvado MD, Alfranca A, Escolano A, Haeggström JZ, Redondo JM. COX-2 Limits Prostanoid Production in Activated HUVECs and Is a Source of PGH2 for Transcellular Metabolism to PGE2 by Tumor Cells. Arterioscler Thromb Vasc Biol (2009) 29:1131-7 |
- Juan Miguel Redondo Moya
- Department Director
- Ext.1150
Dr. Redondo studied for his degree in (Biochemistry, 1982) and his PhD (1987) at the Universidad Autónoma de Madrid. During his doctoral and postdoctoral training he worked in the field of Immunology, mostly on the transcriptional activation and regulation of T lymphocytes and the mechanisms of T cell differentiation. This work was carried out at the Centro de Biología Molecular Severo Ochoa (CBMSO), the Hospital de la Princesa de Madrid, Harvard Medical School, and Duke Medical Center. Dr. Redondo started his own laboratory in 1995, initially at the CBMSO (CSIC/UAM), and his area of interest expanded to the transcriptional regulation of endothelial activation, angiogenesis and inflammation. Much of his work centers on the regulation and function of the calcineurin/NFAT signaling pathway. Apart from its implication in the processes mentioned above, this pathway plays important roles in chronic inflammatory diseases, cardiac hypertrophy and ischemic retinopathy. All of these physiological and pathophysiological processes are the focus of research in Dr. Redondo’s group. Through an agreement with the CSIC, of which he is a Profesor de Investigación, in November 2001 Dr. Redondo joined the CNIC, where he is a Senior Researcher in the Department of Vascular Biology and Inflammation
© 2013 Centro Nacional de Investigaciones Cardiovasculares